Scientists test if eczema drug helps repair Kids' skin shield
NCT ID NCT04718870
Summary
This study aimed to understand how the medication dupilumab affects the skin's protective barrier in children with moderate to severe eczema (atopic dermatitis). It involved 41 children who received the drug, and researchers used a special tape-stripping method to measure how well the skin held moisture on both rashy and normal-looking areas. The goal was to gather detailed information on how the treatment works to improve skin health.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DERMATITIS, ATOPIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site Number :8260001
Sheffield, S10 2TH, United Kingdom
-
Investigational Site Number :8400001
Denver, Colorado, 80206, United States
-
Investigational Site Number :8400002
Los Angeles, California, 90027, United States
Conditions
Explore the condition pages connected to this study.